Survival Benefit with Kidney Transplants from HLA-Incompatible Live Donors

2016348 citationsJournal Articlebronze Open Access

Authors

Babak J. Orandi · Jewish Hospital

Xun Luo · Johns Hopkins University

Allan B. Massie · University of Illinois Chicago

Jacqueline Garonzik‐Wang · Jewish Hospital

Bonnie E. Lonze · University of Illinois Chicago

Rizwan Ahmed · Cornell University

Kyle J. Van Arendonk ·

Abstract

This multicenter study validated single-center evidence that patients who received kidney transplants from HLA-incompatible live donors had a substantial survival benefit as compared with patients who did not undergo transplantation and those who waited for transplants from deceased donors. (Funded by the National Institute of Diabetes and Digestive and Kidney Diseases.).

Topics & Keywords

Renal Transplantation Outcomes and Treatments Organ Donation and Transplantation Renal and Vascular Pathologies

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: New England Journal of Medicine

Volume 374, Issue 10, pp. 940-950

DOI: 10.1056/nejmoa1508380

Field-Weighted Citation Impact: 36.01